5mC-Related lncRNAs as Potential Prognostic Biomarkers in Colon Adenocarcinoma
Globally, colon adenocarcinoma (COAD) is one of the most frequent types of malignant tumors. About 40~50% of patients with advanced colon adenocarcinoma die from recurrence and metastasis. Long non-coding RNAs (lncRNAs) and 5-methylcytosine (5mC) regulatory genes have been demonstrated to involve in...
Main Authors: | Yinghui Huang, Huiqian Huang, Yong Wang, Hui Liu, Yingdan Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/2/231 |
Similar Items
-
Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01) -
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
by: Jie Zhao, et al.
Published: (2022-11-01) -
A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma
by: Fada Xia, et al.
Published: (2021-12-01) -
Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
by: Saiyidan Yalimaimaiti, et al.
Published: (2023-03-01)